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Abstract 
In order to control their release, drugs are encapsulated into systems which are expected to provide a certain site 
with a predetermined amount of drug over a well-defined period of time. Here we report on a multi-component 
drug delivery biomaterial that consists of a hydrogel matrix in which drug-loaded biodegradable microcarriers 
are dispersed, and whose potential applications could be found in the design of implantable devices with long-
term activity, as required by contraceptive and hormone replacement treatments. The release profile of the drug 
can actually be tuned by the complex interplay of several release mechanisms, including the permeability and 
eventually the degradation rate of the microcarriers and the diffusion through the hydrogel. The hydrogel 
consisted of 2-hydroxyethyl methacrylate cross-linked by ethylene glycol dimethacrylate. The microcarriers 
were biodegradable poly-ε-caprolactone (PCL) microspheres in which active molecules, such as levonorgestrel 
(LNG), were encapsulated. The hydrogels were characterized by water swelling, thermal properties, LNG 
diffusion through drug-free and drug-depleted hydrogel membranes and LNG release from devices with drug 
dispersed in the hydrogel. The PCL microspheres were observed by scanning electron microscopy; their size 
distribution, LNG loading and release were also investigated. The hydrogel-microsphere assemblies were 
characterized in terms of the distribution of the microspheres within the hydrogel, water swelling and the release 
of the encapsulated molecules. The developed device, due to its composite structure, has the ability to combine 
several release mechanisms, leading to drug release obeying zero-order kinetics for most of the time. 
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1. Introduction 
Theoretically, an ideal drug delivery system should deliver a drug to a specific site in a specific time and release 
pattern. After more than 40 years of research and development of a large number of systems, polymeric supports 
are integral to the design and preparation of controlled delivery formulations. In fact, the great versatility of 
polymers from a structural point of view, together with the possibility of combining hydrophilic and 
hydrophobic components, as well as polymer-polymer macromolecules, polymer-drug, polymer-solvent or 
polymer-physiological medium interactions, offers huge possibilities for the design and preparation of 
formulations with specific properties and functions. 
Hydrogels are cross-linked polymer networks that are insoluble, but able to swell in water. Due to their close 
resemblance to natural tissues, they have been frequently used for tissue engineering and drug delivery [1-5]. 
Due to   their   biocompatibility,   hydrogels   based   on   poly(2-hydroxyethyl methacrylate) (pHEMA) are 
commercially employed as soft contact lenses and intraocular lenses, and have been investigated for several 
biomedical applications, such as substrates for cellular and tissue engineering [6,7] and drug delivery devices [8-
11]. The release of the drug from hydrogel controlled release systems is affected by the rate of water diffusion 
into the polymer, which in turn depends on the chemical structure of the polymer (polarity, glass transition 
temperature, flexibility of the polymer backbone) and on the cross-link density and inter-chain interactions 
[3,11,12]. 
Poly-ε-caprolactone (PCL) is a biodegradable and biocompatible aliphatic polyester with a semicrystalline 
structure and a very low glass transition temperature. Due to its slow degradation [13-15], high permeability to 
many drugs and low toxicity [16], PCL microcarriers consisting of a drug dispersed in spherical polymer matrix 
have been extensively evaluated for the administration of active compounds over long periods [17-20]. In these 
systems, the drug release is governed by factors depending on the polymer (molecular weight, crystallinity), the 
drug (solubility in water/biological fluids) and their interactions, as well as on the microcarrier's characteristics 
(drug loading, particle size, porosity) [21]. Previous studies have indicated that PCL could retain its integrity in 
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the body over long periods before being metabolized and completely excreted [22,23]. The fact that the 
degradation rate of PCL is relatively slower than those of other known biodegradable polymers makes it suitable 
as a long-term device. By embedding PCL microspheres containing drugs into hydrogels, two different release 
mechanisms can be combined: diffusion through the polymeric matrix for the microcarriers and diffusion 
through the hydrophilic matrix for the hydrogel. With the aid of the different parameters mentioned above, the 
release profile of drugs encapsulated into PCL microspheres, which in turn are embedded in pHEMA-based 
hydrogels, can be tuned to an apparent zero-order and maintained over a long period. Low-dose drug delivery 
devices releasing active principles over a long period could find their application in the field of contraceptives 
and hormone replacement treatments. Intrauterine devices and intrauterine drug delivery devices act locally, 
avoiding systemic effects, and are therefore particularly attractive for contraception or hormone replacement 
therapy in post-menopausal women [24,25]. 
2. Experimental 
2.1. Materials 
2-Hydroxyethyl methacrylate (HEMA) and ethylene glycol dimethacrylate (EGDMA) were purchased from 
Sigma Aldrich and distilled under vacuum or used as received. Freshly prepared aqueous solutions of potassium 
persulfate, K2S2O8 (Sigma Aldrich) and sodium disulfite dry Na2S2O5 (Merck) were used together as redox 
initiators. 
Levonorgestrel (LNG) was purchased from Industriale Chimica (Saronno, Italy). PCL (mol. wt. = 50,000) was 
received as a free sample from Solvay. Poly(vinylalcohol) (PVA) (Mowiol 3-83, mol. wt. = 18,000 g/mol) was 
supplied from Calbiochem, and the Carbomer 980 was from Certa (Belgium). All other chemicals were 
analytical grade and were used as received. 
2.2. Preparation of multi-biomaterial delivery systems 
2.2.1.  Microspheres 
PCL microspheres, blank and loaded with drug, were prepared by the oil in water (o/w) emulsion-solvent 
evaporation method, a technique commonly used for the microencapsulation of water-insoluble drugs within 
hydrophobic polymers [26,27]. PCL and LNG were dissolved in 5 ml dichloromethane, forming the oil phase. 
This organic phase was gradually added into a 250 ml beaker containing 125 ml of 0.27% PVA aqueous 
solution, maintained at room temperature and stirred at 300 rpm to form an o/w emulsion. The emulsion system 
was continuously stirred at room temperature and ambient pressure to allow the evaporation of dichloromethane 
and to let the droplets harden into microspheres. The microspheres were collected by filtration on a filter paper, 
washed three times with distilled water and freeze-dried to obtain free flowing PCL microspheres. 
2.2.2.  Hydrogels 
Dissolved oxygen was removed from monomer mixtures composed of HEMA with 0-0.5 vol.% EGDMA by 
nitrogen bubbling for 5 min. For the preparation of drug-loaded substrates, either appropriate amounts of drug 
were dissolved or appropriate amounts of PCL microspheres encapsulating drug were dispersed in the monomer 
mixture. Subsequently, the organic phase was mixed in reagent glasses in a volume ratio of 3:1 with aqueous 
solutions of redox initiators (6.4 mg of K2S2O8 and 3.2 mg of Na2S2O5 per ml of water). The nitrogen bubbling 
continued for another 15 min, then the reagent glasses were left at room temperature under the nitrogen blanket 
until the gelation of the reaction mass was visible. Finally, the viscous liquid was stirred to achieve a uniform 
composition and was then either aspirated into 1 ml one-way plastic syringes or poured between two glass plates 
kept approximately 1 mm apart by the use of a rubber spacer and left to polymerize overnight at room 
temperature. A series of pHEMA rods embedding increasing amounts of blank PCL microspheres was also 
prepared. 
The pHEMA-based rods and membranes synthesized as above were washed for 5 days with distilled water, with 
daily water changes, for the removal of unreacted monomer (the residual HEMA was less than 5 ppm after 5 
days' washing as determined by high-performance liquid chromatography, HPLC), and then stored either freeze-
dried (rods) or in distilled water (membranes). 
pHEMA-based drug-depleted membranes, used for drug diffusion experiments, were prepared in the presence of 
LNG (at an LNG concentration of 0.01 wt.% in the hydrogel mixture) and subsequently washed for 20 days with 
a 3:1 (v/v) ethanol:water mixture, with daily changes, to ensure the complete extraction of the drug. The drug-
depleted and drug-free hydrogel membranes were then equilibrate in water for another 10 days before the 
diffusion experiments started. The absence of extractable drug was verified by HPLC measurements. 
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2.3. Morphology 
2.3.1.   Visual 
Hydrogel rods embedding different amounts of blank PCL microspheres were removed from the water, blotted 
dry with paper towels and aligned on a grey background. Pictures were taken with a Minolta DiMAGE F300 
digital camera. 
2.3.2. SEM 
PCL microspheres were mounted on aluminium stubs using double-sided tape, sputtered with palladium under 
vacuum and visualized using a JEOL JSM 840A scanning electron microscope. 
Hydrogel rod samples were partially air-dried, cut with a razor blade or with a microtome, dried completely 
under vacuum at room temperature and then prepared for SEM as the microspheres. 
2.4. Size distribution 
Microspheres geometrical diameter was determined using the laser diffractometry principle of Mastersizer® 
2000-Scirocco® 2000 (Malvern Instruments, Malvern, UK), which applies the Mie scattering measurement 
principle. A sample of 100 mg lyophilized microspheres was placed into the tray in the Scirocco feeder. The 
microspheres were continuously supported by a vacuum stream from the tray to the measuring window where 
the sample diffracts the laser beam. Sample dispersion was achieved by accelerating particles within the vacuum 
stream. The geometrical diameter was expressed in terms of volume median diameter, D(v,0.5), as well as D(v, 
0.1) and D(v,0.9). 
2.5. Drug loading 
The drug amount present in the microspheres was determined by dissolving 10 mg of drug-loaded microspheres 
in 3 ml dichloromethane with vigorous stirring to dissolve the polymer. A volume of 10 ml ethanol was added, 
leading to polymer precipitation, then the dichloromethane was evaporated under vacuum. A 1:1 ethanol:water 
mixture was added to the solution containing the drug, which was subsequently filtered using a 0.1 µm Millipore 
filter assembly. After a suitable dilution, the drug content of the sample was determined by HPLC assay. Each 
measurement was conducted in triplicate. 
2.6. Swelling behaviour 
Freeze-dried samples of pHEMA-based hydrogels with embedded blank PCL microspheres were used as the 
starting materials. Dry hydrogel rods were immersed in distilled water at room temperature. At certain time 
intervals, the hydrogel pieces were extracted from water, blotted dry with a paper towel and weighed. 
2.7. Differential scanning calorimetry (DSC) 
The melting temperature (Tm) and glass transition temperature (Tg) were investigated by DSC (DSC Q100, TA 
Instruments). Small fragments of dried pHEMA hydrogel samples embedding blank PCL microspheres, cut from 
different parts of the same sample, were weighed in aluminium pans in triplicate, closed with appropriate 
aluminium lids and subjected to a heating program of 10.0 °C min-1 from 25.0 to 150.0 °C. Tm and Tg were 
determined from the second run. 
2.8. In vitro kinetics 
2.8.1. Drug release kinetics from microspheres 
In vitro LNG release experiments from the microspheres were conducted in triplicate using a USP Apparatus 4 
(Sotax CE7smart and CP 7-35 pump, Sotax, Basel, Switzerland). This method has the advantage of ensuring 
constant optimal sink conditions due to the continuous flow of the solvent [28,29]. Approximately 10 mg of 
microspheres was accurately weighed and placed in the flow-through cells. The study was performed in pH 7.4 
phosphate buffer containing sodium azide (0.025 wt.%) as an antimicrobial agent. The medium was circulated 
through the cells at a constant flow rate of 16 ml min-1. Samples were withdrawn at specific time points and 
analysed by HPLC. After the withdrawal of each sample, fresh buffer was added to the cells to ensure the sink 
condition of the test. 
2.8.2. Drug release kinetics from the device 
Release of drugs from the device was assayed in triplicate under sink conditions. In order to perform the release 
kinetics, devices consisting of microspheres with encapsulated drug, embedded in hydrogel, were placed in glass 
bottles containing 250 ml of phosphate buffer solution (pH 7.4) containing 0.025 wt.% sodium azide. The bottles 
were placed in a shaking water bath (SW 22, Julabo, Seelback, Germany) and shaken at 37 °C. Samples were 
collected at specific time intervals, the withdrawn aliquots being replaced immediately with fresh medium. The 
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amount of released drug was determined by HPLC. 
2.8.3. Drug diffusion through hydrogel membranes  
Hydrogel membranes, cut in appropriate forms, were fixed between the donor and the acceptor chamber of Franz 
cells [30], a Teflon ring ensuring a constant membrane area in contact with the two chambers. The donor 
chambers were filled with a suspension prepared from an aqueous gel of Carbomer 980 (1% in water) and LNG 
(15 wt.% in the suspension). As the receptor medium, water with 0.1% parabens was used. Throughout the 
experiment the receptor medium was stirred at 650 rpm and a temperature of 37 °C was maintained using a water 
thermostat. Samples of 1 ml were withdrawn at specific time points and their LNG content was measured by 
HPLC. The withdrawn volumes were subsequently replaced by fresh receptor medium. 
2.9. Drug assay 
2.9.1. LNG assay 
The HPLC system consisted of a model 1100 LC system with vacuum degasser, quaternary pump, thermostatted 
automatic sample injector, thermostatted column compartment and diode-array detector from Agilent 
Technologies. Fifty microliter samples were injected on a Lichrocart column (250 x 4 mm) prepared with a 
Lichrospher 100 RP-18 5 µm phase (Merck®). The temperature of the column was maintained at 30 °C. The 
mobile phase, composed of 60/40 mixture of acetonitrile and water, had a flow rate of l.0 ml min-1. All samples 
were assayed at 245 nm. This method was successfully validated and showed a good linearity, reproducibility 
and accuracy from 30.0 to 800.0 ng ml-1. 
3. Results and discussion 
3.1. Micro spheres 
3.1.1. Size distribution and drug loading 
The experimental conditions and corresponding values of particle size distribution, drug loading and entrapment 
efficiencies (DEE) for each sample are summarized in Table 1. The entrapment efficiency of drug in 
microspheres was determined using the following relation: 
 
Drug loading values of PCL microspheres containing LNG were found to be 8.2 ±0.2% and 12.4 ±3.6%, 
respectively for the two samples. The DEE for the batches A and B were 79.5 ± 3.2% and 62.2 ± 4.8%, 
respectively. 
The relatively low DEE suggests the low solubility of the LNG within PCL, a behaviour already shown for other 
steroid drug (progesterone) in biodegradable polymers [31]. 
The viscosity of PCL solutions depends directly on polymer concentration, organic solvent and temperature. 
Accordingly, an increase in the polymer concentration produced a significant increase in the viscosity, thus 
leading to an increase in the emulsion droplet size and finally to a higher PCL microsphere size. Moreover, the 
high concentration of polymer in the emulsion droplets led to an enhancement of the encapsulation efficiency, 
because the high viscosity of the organic phase tends to restrict the drug partitioning into the external aqueous 
phase [32]. The viscosity of the organic phase presumably increased even more upon addition of LNG, the drug-
loaded microspheres (sample B) having a larger particle size than the blank ones (sample C). 
 
Table 1: Effect of the processing parameters on the size, drug loading and encapsulation efficiency of PCL 





PCL concentration in 
CH2Cl2 solution (%) 















A 50 500 0.100 250.0 ± 19.5 345.8 ± 16.0 456.6 ± 39.1 8.2 ± 0.2 79.5 ± 3.2 
B 100 500 0.025 117.9 ±29.1 223.2 ± 22.5 392.4 ± 91.4 12.7 ± 1.6 62.2 ± 4.8 
C - 500 0.025 48.4 ± 1.8 93.2 ±2.5 165.6 ± 5.2 - - 
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3.1.2. Morphology 
SEM micrographs of the blank microspheres showed quite smooth surfaces with a few pores, probably due to the 
evaporation of dichloromethane during the emulsion-evaporation process. The particles appeared to be 
homogeneously distributed, without evidence of collapsed particles. The drug-loaded microspheres showed a 
certain surface roughness (Fig. lb) and a larger particle size than the blank microspheres. 
 
Fig. 1: SEM micrographs of PCL microspheres: (a) blank and (b) encapsulating LNG. 
 
 
3.1.3. Drug release 
The drug release kinetics of LNG from PCL microspheres were analysed by plotting the cumulative release data 
of LNG against time. The release behaviour of LNG from PCL microspheres in comparison with the release of 
LNG crystals is illustrated in Fig. 2, which indicates the continuous release of PCL from microspheres for more 
than 4 months. 
At the initial stage of microsphere release, the burst effect related to the drug entrapped near the surface of the 
microspheres was small and followed by a slow release phase. The low permeability of PCL with regard to water 
caused the delay of water penetration in the microspheres, leading to the low burst effect [13,15]. At the later 
stage, the drug was released more slowly, with a rate determined by the diffusion of the drug through the 
polymer matrix. For the characterization of the release mechanism of LNG from PCL microspheres we have 
applied a mathematical model of the release profile, using Eq. (2), proposed by Sinclair and Peppas [33] for the 
diffusional release from a spherical matrix 
 
where Mt/M∞ is the fractional drug release at the time t, k is a constant characteristic of the polymer-drug 
interaction and n is the diffusional exponent (0.432 for Fickian diffusional release from a spherical matrix). 
The experimental values fitted the theoretical curve, built with an n value of 0.432 (R2 = 0.97). Consequently, the 
main mechanism leading to the release of the drug from the microspheres is diffusion through the polymeric 
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Fig. 2: In vitro release profiles from LNG crystals and PCL microspheres encapsulating LNG. 
 
 
3.2. Hydro gels 
pHEMA hydrogels prepared with different percentages of cross-linker, such as 0.10%, 0.25% and 0.50% 
EGDMA, did not show any significant differences in their aspect and investigated properties (such as water 
uptake and water swelling kinetics, glass temperature transition, drug diffusion experiments), typical for this 
range of relatively low cross-linker concentrations [12]. The hydrophobicity increase due to the cross-linker is 
too low to bring significant changes to the water diffusion into the hydrogel, and the decrease of the network 
mesh is not restrictive enough for the diffusion of small molecules. Similarly, the changes in the thermal 
properties are too small to be detected by DSC. Therefore, the results of the present study will concern only 
pHEMA hydrogels with 0.1% EGDMA. 
3.2.1.  Morphology 
3.2.1.1.   Visual. The diameter of hydrogel rods remained constant after swelling (4.8 mm), regardless of the 
amount of PCL microspheres embedded into the hydrogels in the range between 0 and 100 mg per ml of 
hydrogel. With increasing microsphere content, the hydrogel rods, which were still transparent up to a content of 
approximately 30 mg per ml of hydrogel, lost their transparency. 
3.2.1.2.  SEM. The composite rods with PCL microspheres showed good incorporation of the microspheres into 
the hydrogel bulk, with uniform distribution of the microspheres at the cut level (Fig. 3). Moreover, the 
microsphere integrity was fully preserved, proving the physical embedding of the microspheres into the 
hydrogel. 
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3.2.2.   Water uptake 
pHEMA hydrogels are known to exhibit a narrow range of swelling at equilibrium in water, ranging from 39% to 
42% water for the fully swollen hydrogels [34,35], regardless of the dilution of the starting monomer solution 
and its content of cross-linking agent [36]. The same behaviour was seen for the samples prepared in the 
framework of the present study. Moreover, for the preparations embedding microspheres, the presence of the 
microspheres seemed not to have any major influence on the swelling behaviour of the pHEMA hydrogels 
containing PCL microspheres. 
The description of water diffusion into hydrogels is based on Fick's hypothesis [12,37], which assumes 
proportionality between the flux and the concentration gradient of the physical quantity diffused. A direct 
consequence of this is that the diffusion along a concentration gradient is expected to scale as t1/2 in 
homogeneous and isotropic systems. Fickian diffusion occurs when the diffusion rate of water into the hydrogel 
is much slower than the relaxation rate of the polymer chains of hydrogel. 
The water uptake (Sw) of hydrogel rods embedding blank PCL microspheres at the time t was calculated 
according to Eq. (3), where Sw is shown as the exponential function of time (t) in the second part of the equation 
 
where mt is the weight at the time t, md is the dry weight, k is a constant related to the network structure and n is 
the number indicating the diffusion type. 
 
To evaluate the values of n and k, curves were fitted through the first experimental points on the water uptake 
curves of pHEMA hydrogels incorporating different amounts of blank PCL microspheres. The corresponding 
values are listed in Table 2. The values for n are all very close to 0.45 (value calculated for cylindrical 
geometry), indicating the Fickian behaviour during water swelling of all hydrogels investigated, and the values 
for k point out the reproducibility of the network structure in the experimental conditions used. 
 
Table 2: Water uptake parameters for hydrogels embedding PCL microspheres 
Blank PCL microspheres content 
of pHEMA hydrogel samples (mg 
per ml of hydrogel) 
Water uptake (% of the 
blank hydrogel water 
uptake) 
k n 
0 100.00 0.1344 0.4721 
5 100.56 0.1376 0.4506 
10 102.35 0.1531 0.4244 
15 101.06 0.1336 0.4594 
20 100.86 0.1384 0.4606 
25 100.56 0.1336 0.4595 
30 99.33 0.1350 0.4602 
 
3.2.3.  Thermal analysis 
Fig. 4 shows the thermal characteristics of the multi-material, identified by DSC measurements. pHEMA 
hydrogel is characterized by the glass transition at temperatures around 115-116 °C, and drug-free PCL 
microspheres are characterized by the melting temperature around 55 °C. Similar values obtained for the 
composites suggest the physical entrapment of the microspheres into the hydrogel matrix, without any chemical 
interactions. 
Furthermore, the technique allows the quantitative evaluation of the microsphere loading, the area of the 
endothermic peak at around 55 °C being proportional to the PCL microsphere loading for the hydrogel samples 
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3.2.4.  In vitro drug diffusion and release 
The probe solute size and shape, its hydrophilic and hydrophobic character, and the availability of "free" water 
molecules to hydrate and dissolve the solute molecules are important factors governing the solute permeation 
through any particular hydrogel [2]. The drug can be loaded into the hydrogel by either equilibrium partitioning 
or cross-linking of the matrix in the presence of the drug. Variations in the release rate of the drug can be 
achieved by changing the nature, type and structure of the substrate. By employing several synthetic 
methodologies, the density of the matrix and also the solubility of the migrating substance in the polymeric 
network could be finely tuned. 
Because, in our case, different release mechanisms contributed to the final release rate of the drugs, the influence 
of the individual components of the device on the release rate of LNG was investigated. 
3.2.4.1. Drug diffusion through hydrogel membranes. The results of permeation experiments were analysed 
using the time lag model (Eq. (4)), which allowed the calculation of the diffusion coefficient of LNG through 
pHEMA membranes from the time-axis intercept of the plot of cumulative weight of diffused drug per unit area 
(µg cm-2) as a function of time (s) [38,39] 
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where D is the diffusion coefficient, l is the thickness of the membrane and tlag is the time-axis intercept of the 
cumulative release plot. 
 
The value obtained for the diffusion coefficient of LNG through blank pHEMA membranes was (1.58 ± 0.24) x 
10-8 cm2 s-1, a typical value of the diffusion coefficient in swollen hydrogels [39,40]. The diffusion experiment 
using drug-depleted membranes led to a value of the diffusion coefficient of (2.83 ± 0.09) x 10-8 cm2 s-1, which 
suggests either a partial molecular imprinting of the hydrogel (unlikely when the synthesis is performed at low 
percentages of cross-linker) or a slight widening of the hydrogel network due to the possible extraction of low 
molecular weight species (oligomers) during the washing step with the water/ ethanol mixtures. 
3.2.4.2. Drug release. Fig. 6 illustrates the release profile of LNG from different devices. The first device type 
consisted of hydrogel rods containing the drug directly dispersed in hydrogel; the second device contained 
polymeric microspheres encapsulating the drug, dispersed in the hydrogel. The hydrogel alone was unable to 
achieve a sustained release of the drug. After 10 days, the LNG-hydrogel device had released almost 80% of the 
total dispersed drug. 
 
Fig. 6: Release profiles of LNG from hydrogel rods following: (a) LNG encapsulation in microspheres and 
embedding of microspheres in hydrogel or (b) LNG dispersion in hydrogel. 
 
 
The significant change in the slope of the release profile in the second release stage suggested an incomplete 
release, because the hydrophobic drug may associate with the hydrophobic domains of the hydrogel [39]. 
The multi-component biomaterial including microspheres in the hydrogel matrix showed continuous LNG 
release for more than 2 months. During the first release stage, the device including microspheres only released 
42% of the total LNG in a "burst", followed by a constant release characterized by zero-order kinetics (R2 = 
0.997). 
The release rate was surprisingly high compared with the release rate of the microspheres encapsulating LNG. 
This behaviour can be explained by the different conditions in which the release experiments for the different 
materials were performed, as well as by the markedly hydrophobic character of LNG and its consequently higher 
solubility in HEMA monomer than in water (the water solubility of LNG is 1.12 µg ml-1 at 37 °C). For high 
encapsulation yields of LNG in PCL microspheres, crystals of LNG lying on the surface of the microspheres 
dissolve in the monomer mixture before the gelation starts, leading to the molecular dispersion of part of the 
drug in the hydrogel matrix and to an increase in the overall porosity of the microspheres. 
Molecular dispersions of drugs in cross-linked hydrogels -currently being investigated for the delivery 
enhancement of poorly water-soluble drugs [41] - could be the reason for the fast release of the LNG in the first 
stage. The permeability of drug-free and drug-depleted membranes of pHEMA towards steroids has been already 
investigated, with similar results [42]. On the other hand, microcarriers with higher porosity will have higher 
release, fact which accounts for higher release rates in the subsequent stage for the microspheres embedded in 
hydrogel when compared with the microspheres alone. 
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Certainly there are situations when an initial burst followed by a prolonged release could be advantageous, for 
example, for wound treatment or targeted delivery [43], but for long-term controlled release devices, the burst is 
often regarded as a negative aspect. Therefore we started to devise several strategies for decreasing the burst in 
the system described above. The simplest one consists of washing the microspheres prior to their dispersion in 
the monomer mixture. Other attempts will deal with the coating of the microspheres containing drug, or with 
their production using a system that allows better encapsulation of the drug in the bulk of the microspheres. 
4. Conclusions 
This study was undertaken to confirm the feasibility of a multi-biomaterial system comprising microspheres 
embedded in a hydrogel matrix. The use of the multi-component drug delivery biomaterial enables the drug 
release to obey zero-order kinetics for most of the time, and allows different release kinetics for drugs contained 
in the same device but encapsulated either directly in the hydrogel or in the microcarriers. The hydrogel is 
therefore not only a physical support for the drug-loaded microspheres, building the body of a device which 
could be, for instance, easily implanted and/or inserted and removed, but also acts as a hydrophilic matrix for the 
encapsulation of additional drugs. This ability of the hydrogel can be further developed by performing the co-
polymerization of the HEMA with a hydrophobic co-monomer, such as methyl methacrylate. Encapsulation of 
various drugs, including temperature-and organic solvent-sensitive ones, is possible, as the hydrogel synthesis 
does not use organic solvents or have high reaction temperatures. Potential applications could be found in the 
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